Phase II Clinical Trial of Interleukin-2 in AD
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT06096090
- Locations
- 🇺🇸
Houston Methodist Research Institute, Houston, Texas, United States
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
Not Applicable
Recruiting
- Conditions
- Overactive BladderNeurogenic BladderMultiple Sclerosis
- Interventions
- Device: Magstim Rapid2 System
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 29
- Registration Number
- NCT06072703
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction
Not Applicable
Recruiting
- Conditions
- Neuro: Neurogenic BladderOveractive BladderNeurogenic Detrusor OveractivityLower Urinary Tract SymptomsNeurogenic Bladder
- Interventions
- Procedure: Standard number of injection sitesProcedure: Reduced number of injection sites
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 78
- Registration Number
- NCT06059066
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Sleep & Stress in Healthcare Providers After Defined Music Intervention Measure by 7-Tesla fMRI & Actigraphy
Not Applicable
Completed
- Conditions
- Sleep DeprivationStress, PsychologicalMusic TherapyBurnout, Professional
- Interventions
- Other: Music Therapy, self-selectedOther: Music Therapy, prescribed
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 16
- Registration Number
- NCT05980429
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
IO Vancomycin in TSA
Phase 4
Recruiting
- Conditions
- Shoulder Injuries
- Interventions
- Drug: Control - Standard IV administration of vancomycinDrug: Intervention - Intraosseous (IO) administration of vancomycin
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2023-08-09
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT05831774
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Low Dose IL2 Immunotherapy in AD
Phase 1
Completed
- Conditions
- Alzheimer Disease
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2023-04-20
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 8
- Registration Number
- NCT05821153
- Locations
- 🇺🇸
Alireza Faridar, Houston, Texas, United States
IO vs IV Vancomycin in Tourniquetless TKA
Phase 4
Recruiting
- Conditions
- Infection, Surgical Site
- Interventions
- Drug: Intravenous VancomycinDrug: Intraosseous Vancomycin Injection
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT05705843
- Locations
- 🇺🇸
Houston Methodist Hospital Outpatient Center, Houston, Texas, United States
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
Phase 2
Recruiting
- Conditions
- HER2-negative Breast CancerMetastatic Breast CancerMetaplastic Breast CarcinomaTNBC - Triple-Negative Breast Cancer
- Interventions
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 36
- Registration Number
- NCT05660083
- Locations
- 🇺🇸
Houston Methodist Neal Cancer Center, Houston, Texas, United States
Procedural Discomfort Related to Number of Intradetrusor Botox Injections
Phase 4
Recruiting
- Conditions
- Overactive Bladder
- Interventions
- Biological: Intradetrusor Botox Injections
- First Posted Date
- 2022-12-15
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 131
- Registration Number
- NCT05652036
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Usability, Acceptability, and Safety of Virtual Reality-based Cognitive Intervention
Not Applicable
Completed
- Conditions
- Virtual Reality
- Interventions
- Other: Virtual Reality Software
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 30
- Registration Number
- NCT05583903
- Locations
- 🇺🇸
Houston Methodist Research Institute, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath